Eli Lilly and Co. said it will cut prices of its most commonly prescribed insulins up to 70% and expand a program that limits out-of-pocket monthly costs for some consumers. The Indianapolis drugmaker's price cuts and discounts for insulin come as federal and state lawmakers and patient advocates pressure drug companies and health insurers to improve affordability for the lifesaving medication used by millions of Americans. “The aggressive price cuts we’re announcing today should make a real difference for Americans with diabetes," said Lilly Chair and CEO David Ricks. Visit the link in bio to learn more about the price cut.